These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 19087221

  • 1. Soluble thrombomodulin partially corrects the premature lysis defect in FVIII-deficient plasma by stimulating the activation of thrombin activatable fibrinolysis inhibitor.
    Foley JH, Nesheim ME.
    J Thromb Haemost; 2009 Mar; 7(3):453-9. PubMed ID: 19087221
    [Abstract] [Full Text] [Related]

  • 2. Platelet factor 4 inhibits thrombomodulin-dependent activation of thrombin-activatable fibrinolysis inhibitor (TAFI) by thrombin.
    Mosnier LO.
    J Biol Chem; 2011 Jan 07; 286(1):502-10. PubMed ID: 21041299
    [Abstract] [Full Text] [Related]

  • 3. Thrombin activatable fibrinolysis inhibitor activation and bleeding in haemophilia A.
    Foley JH, Nesheim ME, Rivard GE, Brummel-Ziedins KE.
    Haemophilia; 2012 May 07; 18(3):e316-22. PubMed ID: 21933309
    [Abstract] [Full Text] [Related]

  • 4. Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin-independent impairment of the thrombin-activatable fibrinolysis inhibitor pathway.
    Colucci M, Incampo F, Cannavò A, Menegatti M, Siboni SM, Zaccaria F, Semeraro N, Peyvandi F.
    J Thromb Haemost; 2016 Aug 07; 14(8):1603-14. PubMed ID: 27094709
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of thrombomodulin/thrombin activatable fibrinolysis inhibitor function in plasma using tissue-type plasminogen activator-induced plasma clot lysis time.
    Urano T, Sano Y, Suzuki Y, Okada M, Sano H, Honkura N, Morooka N, Doi M, Suzuki Y.
    Res Pract Thromb Haemost; 2024 May 07; 8(4):102463. PubMed ID: 39026660
    [Abstract] [Full Text] [Related]

  • 6. Thrombin activatable fibrinolysis inhibitor pathway alterations correlate with bleeding phenotype in patients with severe hemophilia A.
    Semeraro F, Mancuso ME, Ammollo CT, Dirienzo L, Vitulli A, Santagostino E, Tripodi A, Colucci M.
    J Thromb Haemost; 2020 Feb 07; 18(2):381-389. PubMed ID: 31571361
    [Abstract] [Full Text] [Related]

  • 7. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma.
    Broze GJ, Higuchi DA.
    Blood; 1996 Nov 15; 88(10):3815-23. PubMed ID: 8916945
    [Abstract] [Full Text] [Related]

  • 8. The defective down regulation of fibrinolysis in haemophilia A can be restored by increasing the TAFI plasma concentration.
    Mosnier LO, Lisman T, van den Berg HM, Nieuwenhuis HK, Meijers JC, Bouma BN.
    Thromb Haemost; 2001 Oct 15; 86(4):1035-9. PubMed ID: 11686321
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. On-demand but not prophylactic treatment with FVIII concentrate increase thrombin activatable fibrinolysis inhibitor activation in severe haemophilia A patients.
    Mikovic D, Woodhams BJ, Holmström M, Elezovic I, Antovic A, Mobarrez F, Elfvinge P, Antovic JP.
    Int J Lab Hematol; 2012 Feb 15; 34(1):35-40. PubMed ID: 21707936
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor.
    Bajzar L, Nesheim M, Morser J, Tracy PB.
    J Biol Chem; 1998 Jan 30; 273(5):2792-8. PubMed ID: 9446587
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Selective modulation of thrombin-activatable fibrinolysis inhibitor (TAFI) activation by thrombin or the thrombin-thrombomodulin complex using TAFI-derived peptides.
    Plug T, Marquart JA, Marx PF, Meijers JC.
    J Thromb Haemost; 2015 Nov 30; 13(11):2093-101. PubMed ID: 26341360
    [Abstract] [Full Text] [Related]

  • 16. Defective TAFI activation in hemophilia A mice is a major contributor to joint bleeding.
    Wyseure T, Cooke EJ, Declerck PJ, Behrendt N, Meijers JCM, von Drygalski A, Mosnier LO.
    Blood; 2018 Oct 11; 132(15):1593-1603. PubMed ID: 30026184
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Reversible inhibitors of TAFIa can both promote and inhibit fibrinolysis.
    Schneider M, Nesheim M.
    J Thromb Haemost; 2003 Jan 11; 1(1):147-54. PubMed ID: 12871552
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties.
    Boffa MB, Wang W, Bajzar L, Nesheim ME.
    J Biol Chem; 1998 Jan 23; 273(4):2127-35. PubMed ID: 9442053
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.